Ascorbic acid in Charcot—Marie—Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial The Lancet Neurology, 04/05/2011

Pareyson D et al. – Ascorbic acid supplementation had no significant effect on neuropathy compared with placebo after 2 years, suggesting that no evidence is available to support treatment with ascorbic acid in adults with Charcot—Marie—Tooth disease type 1AV

Read this article on The Lancet Neurology